Elutia (ELUT) Cash from Investing Activities (2019 - 2026)
Elutia recorded quarterly Cash from Investing Activities of -$34000.0 in Q1 2026, down 100.04% quarter-over-quarter from $79.6 million in Q4 2025, and up 87.77% year-over-year from -$18107.3 in Q1 2025.
Elutia's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$34000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 87.77% year-over-year to -$34000.0; the TTM figure through Mar 2026 stood at $78.8 million (up 10792.4% YoY), while the FY2025 annual figure was $78.6 million, up 16673.63% from the prior year.
- Cash from Investing Activities came in at -$34000.0 for Q1 2026 at Elutia, down from $79.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $79.6 million in Q4 2025 to a low of -$630000.0 in Q3 2025.
- A 5-year average of $5.4 million and a median of -$94000.0 in 2024 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 84760.64% in 2025 and fell as far as 1753.33% in 2025.
- Elutia's Cash from Investing Activities stood at -$134000.0 in 2022, then jumped by 10948.51% to $14.5 million in 2023, then tumbled by 100.65% to -$94000.0 in 2024, then jumped by 84760.64% to $79.6 million in 2025, then sank by 100.04% to -$34000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$34000.0, $79.6 million, and -$630000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | -34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Dec 31, 2025 | 79.58 Mn |
| Dec 31, 2025 | 79.58 Mn |
| Sep 30, 2025 | -630,000.00 |
| Sep 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | 14.54 Mn |
| Dec 31, 2023 | 14.54 Mn |
| Sep 30, 2023 | -62,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -85,000.00 |
| Jun 30, 2023 | -85,000.00 |
| Mar 31, 2023 | -182,000.00 |
| Mar 31, 2023 | -182,000.00 |
| Dec 31, 2022 | -134,000.00 |
| Dec 31, 2022 | -134,000.00 |
| Sep 30, 2022 | -117,000.00 |
| Sep 30, 2022 | -117,000.00 |
| Jun 30, 2022 | -255,000.00 |
| Jun 30, 2022 | -255,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Sep 30, 2021 | -97,000.00 |
| Sep 30, 2021 | -97,000.00 |
| Jun 30, 2021 | -116,000.00 |
| Jun 30, 2021 | -116,000.00 |
| Mar 31, 2021 | -131,000.00 |
| Mar 31, 2021 | -131,000.00 |
| Dec 31, 2020 | -115,000.00 |
| Dec 31, 2020 | -115,000.00 |
| Sep 30, 2020 | -436,000.00 |
| Sep 30, 2020 | -436,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Mar 31, 2020 | -62,000.00 |
| Mar 31, 2020 | -62,000.00 |
| Dec 31, 2019 | -155,000.00 |
| Dec 31, 2019 | -155,000.00 |